Interdisciplinary Approach to Soft Tissue Sarcoma Care: Bridging Gaps for Better Outcomes
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 20 September 2024 | Viewed by 119
Special Issue Editor
2. Chief of Division of Orthopedic Oncology, Miami Cancer Institute, Baptist Health System South Florida, Miami, FL 33176, USA
Interests: soft tissue sarcomas; bone sarcomas; surgical treatment of musculoskeletal metastatic disease; limb salvage surgery; complex reconstruction of extremities; hemipelvectomies; benign soft tissue masses
Special Issue Information
Dear Colleagues,
Soft tissue sarcomas are a heterogeneous group of tumors with more than 70 subtypes representing 1% of adult cancers. These tumors have an aggressive behavior with a 5-year overall survival of about 65% and as low as 20% when there is metastatic disease. A multidisciplinary approach in sarcoma centers is the optimal way of managing these patients including a wide range of specialties. There have been recent advancements regarding systemic treatment evolving from traditional chemotherapy to a more targeted therapy based on molecular findings. Also, there are evolving protocols within the radiation field decreasing the time of treatments and modifying radiation doses helping the patient navigate a more tolerable treatment, decreasing complication rates but keeping adequate local control rates. In surgery, limb salvage procedures are the standard of care, and different methods have been developed to preserve as much function as possible within adequate oncologic control. Unfortunately, there are some patients undergoing resections without following oncologic principles with an impact on their overall prognosis. It is our purpose to present a comprehensive review of the state of the art in the treatment of these tumors, emphasizing the importance for these patients to be managed at sarcoma centers so we can avoid poor outcomes.
Dr. Juan Pretell-Mazzini
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multidisciplinary treatment approach for soft tissue sarcomas
- epidemiology
- classification
- diagnostic modalities
- treatment options
- survival
